CONQUER demonstrated body weight reduction from baseline of 10.2%, and 7.8%, with high (15/92 mg), and medium (7.50/46.0 mg), doses of PHEN/TPM, respectively, (vs
A patient I have been working with recently was diagnosed with interstitial cystitis/bladder pain syndrome in her early 30s, she was prescribed Elmiron (a medication commonly used to treat Hunners lesion subtype) and this worked for her for many years and was under control with minimal to no symptoms
Significant improvements were observed in the tingling, thermal pain and allodynia categories (p values 0.01, 0.04 and 0.04
However, more water means a shorter usable window if you are drawing large volumes relative to the total solution
The users who report transformational results are those who commit to 812 week protocols, maintain dosing consistency, store their peptides correctly, and combine the stack with appropriate load management and recovery practices
Why are BPC-157 and TB-500 studied together